| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R42TR004338 | Novel strategy to block AAV neutralizing antibody activity | 000 | 2 | NIH | 1/6/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $993,865 ) |
| | 2025 | 2025 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R42TR004338 | Novel strategy to block AAV neutralizing antibody activity | 000 | 2 | NIH | 8/12/2025 | $993,865 |
| | 2025 | 2025 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R42TR004338 | Novel strategy to block AAV neutralizing antibody activity | 001 | 2 | NIH | 9/3/2025 | $0 |
| | 2025 | 2023 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41TR004338 | Development of an Effective Strategy to Block Nab Activity for AAV Brain Transduction | 000 | 1 | NIH | 7/30/2025 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $269,640 ) |
| | 2023 | 2023 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41TR004338 | Development of an Effective Strategy to Block Nab Activity for AAV Brain Transduction | 000 | 1 | NIH | 3/30/2023 | $269,640 |
| | 2023 | 2023 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41TR004338 | Development of an Effective Strategy to Block Nab Activity for AAV Brain Transduction | 001 | 1 | NIH | 9/26/2023 | $0 |
| | 2023 | 2020 | NABGEN INC | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41AI155038 | Novel strategy to block AAV neutralizing anitbody activity | 000 | 1 | NIH | 9/12/2023 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | NABGEN, INC. | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41AI155038 | Novel strategy to block AAV neutralizing anitbody activity | 000 | 1 | NIH | 1/20/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $300,000 ) |
| | 2020 | 2020 | NABGEN, INC. | 119 W PIEDMONT AVE | DURHAM | NC | 27707-1743 | DURHAM | USA | R41AI155038 | Novel strategy to block AAV neutralizing anitbody activity | 000 | 1 | NIH | 7/30/2020 | $300,000 |
|
|
